Pharmacists will have more freedom in choosing an alternative HRT Products if the original recipe is not in stock.
The government’s HRT Supply Taskforce, set up to tackle widespread shortages, agreed on further Serious Deficit Protocols (SSPs) to give pharmacists more control – whatever they demanded.
This means that women can offer another product at the pharmacy to relieve symptoms if their normal HRT is not in stock.
At the end of April, Government Released three SSPs to limit the delivery of low doses of estrogel, ovestin, and premix for up to three months to help reduce pressure in the system.
Two new follow-up SSPs are Lenzetto for transdermal spray and Sandrena gel, which will also be available for three months.
As a rule, all of these items can generally be replaced with transdermal spots.
Thousands of menopausal women struggled to get basic medicines, which led to online exchanges and the offering of medicines on the black market.
In a new statement, the government said it had recently launched deliveries of the popular products Oestrogel, Ovestin and Premique Low Dose.
Premique now has good availability, he said, while manufacturers of Oestrogel and Ovestin are working to increase UK supply.
Secretary of Health and Social Welfare, Sajid JavidHe said: “We are working to make HRT accessible to anyone who needs it and I am pleased that suppliers continue to increase the supply of some products, which is a testament to the collaborative approach.
“Meetings with suppliers are ongoing and we are taking decisive action to manage HRT delivery issues and reduce any delays – this includes issuing further SSPs to enable women to access the medicines they need.”
Pharmacists are also allowed to share medications, if needed.
Professor Claire Anderson, President Royal Pharmaceutical SocietyHe said: “We welcome the news that more SSPs have been created for hormone replacement therapy products.
“This short-term measure will help women gain access to HRT medicines that are hard to come by.
“This is a very liquid situation, some products will soon return to normal availability.
However, the bureaucracy involved in completing the SSP process for each individual patient is quite difficult for pharmacists and we hope that the shortage of HRT products will be resolved as soon as possible, under the leadership of the new HRT King.
“Finally, we want to see a change in the law that simplifies and speeds up the whole process for both pharmacists and patients.
“Tips on which HRT product to replace with others are compiled by experts and women can be confident that they will get what is right for them.
“Women should talk to a pharmacist if they have any concerns about their HRT medication.”
Madeleine McTernan, Head of HRT Supply Taskforce, said: “I am very encouraged by the constructive involvement and enthusiasm of the sector as suppliers and pharmacists try to work with us to meet this challenge.
“It is important to focus on the measures that will ensure the most efficient use of supplies, as well as on increasing supply.”
Pharmacists will offer HRT alternatives to overcome supply shortages
Source link Pharmacists will offer HRT alternatives to overcome supply shortages